Literature DB >> 35747168

Glucose Metabolism Intervention-Facilitated Nanomedicine Therapy.

Zhiyan Li1, Xianghui Li1, Shichao Ai1, Song Liu1, Wenxian Guan1.   

Abstract

Ordinarily, cancer cells possess features of abnormally increased nutrient intake and metabolic pathways. The disorder of glucose metabolism is the most important among them. Therefore, starvation therapy targeting glucose metabolism specifically, which results in metabolic disorders, restricted synthesis, and inhibition of tumor growth, has been developed for cancer therapy. However, issues such as inadequate targeting effectiveness and drug tolerance impede their clinical transformation. In recent years, nanomaterial-assisted starvation treatment has made significant progress in addressing these challenges, whether as a monotherapy or in combination with other medications. Herein, representative researches on the construction of nanosystems conducting starvation therapy are introduced. Elaborate designs and interactions between different treatment mechanisms are meticulously mentioned. Not only are traditional treatments based on glucose oxidase involved, but also newly sprung small molecule agents targeting glucose metabolism. The obstacles and potential for advancing these anticancer therapies were also highlighted in this review.
© 2022 Li et al.

Entities:  

Keywords:  cancer metabolism; combined therapy; nanomedicine; starvation therapy

Mesh:

Substances:

Year:  2022        PMID: 35747168      PMCID: PMC9213040          DOI: 10.2147/IJN.S364840

Source DB:  PubMed          Journal:  Int J Nanomedicine        ISSN: 1176-9114


  223 in total

1.  Recent advances in the development of metal-organic framework-based gas-releasing nanoplatforms for synergistic cancer therapy.

Authors:  Danni Jin; Jianan Zhang; Youyou Huang; Xiru Qin; Jiayi Zhuang; Wujie Yin; Sijie Chen; Yang Wang; Ping Hua; Yong Yao
Journal:  Dalton Trans       Date:  2021-02-02       Impact factor: 4.390

Review 2.  Spotlight on 17-AAG as an Hsp90 inhibitor for molecular targeted cancer treatment.

Authors:  Sona Talaei; Hassan Mellatyar; Asadollah Asadi; Abolfazl Akbarzadeh; Roghayeh Sheervalilou; Nosratollah Zarghami
Journal:  Chem Biol Drug Des       Date:  2019-02-14       Impact factor: 2.817

3.  A dual-catalytic nanoreactor for synergistic chemodynamic-starvation therapy toward tumor metastasis suppression.

Authors:  Huiwen Zhang; Fei Lu; Wei Pan; Yegang Ge; Bingjie Cui; Shaohua Gong; Na Li; Bo Tang
Journal:  Biomater Sci       Date:  2021-04-21       Impact factor: 6.843

4.  Combined Fenton and starvation therapies using hemoglobin and glucose oxidase.

Authors:  Hadi Ranji-Burachaloo; Amin Reyhani; Paul A Gurr; Dave E Dunstan; Greg G Qiao
Journal:  Nanoscale       Date:  2019-03-21       Impact factor: 7.790

5.  Dual Targeting Smart Drug Delivery System for Multimodal Synergistic Combination Cancer Therapy with Reduced Cardiotoxicity.

Authors:  Quazi T H Shubhra; Kai Guo; Yixuan Liu; Md Razzak; Md Serajum Manir; A K M Moshiul Alam
Journal:  Acta Biomater       Date:  2021-06-14       Impact factor: 8.947

6.  Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.

Authors:  Chih-Hao Chang; Jing Qiu; David O'Sullivan; Michael D Buck; Takuro Noguchi; Jonathan D Curtis; Qiongyu Chen; Mariel Gindin; Matthew M Gubin; Gerritje J W van der Windt; Elena Tonc; Robert D Schreiber; Edward J Pearce; Erika L Pearce
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

7.  Width-Consistent Mesoporous Silica Nanorods with a Precisely Controlled Aspect Ratio for Lysosome Dysfunctional Synergistic Chemotherapy/Photothermal Therapy/Starvation Therapy/Oxidative Therapy.

Authors:  Junna Lu; Fengyu Liu; Hongjuan Li; Yongqian Xu; Shiguo Sun
Journal:  ACS Appl Mater Interfaces       Date:  2020-05-19       Impact factor: 9.229

8.  Multivalency-assisted membrane-penetrating siRNA delivery sensitizes photothermal ablation via inhibition of tumor glycolysis metabolism.

Authors:  Juanjuan Dang; Huan Ye; Yongjuan Li; Qiujun Liang; Xudong Li; Lichen Yin
Journal:  Biomaterials       Date:  2019-08-30       Impact factor: 12.479

9.  Metformin partially reverses the carboplatin-resistance in NSCLC by inhibiting glucose metabolism.

Authors:  Yong Liu; Chunxi He; Xianping Huang
Journal:  Oncotarget       Date:  2017-09-06

10.  Temperature-feedback upconversion nanocomposite for accurate photothermal therapy at facile temperature.

Authors:  Xingjun Zhu; Wei Feng; Jian Chang; Yan-Wen Tan; Jiachang Li; Min Chen; Yun Sun; Fuyou Li
Journal:  Nat Commun       Date:  2016-02-04       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.